http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101172974-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd921691c069d228a39caafdd5b4517d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
filingDate 2007-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fe28db1d85058ccab178375c9de9e5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bbef3901afde52ccee2bffbda89305d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_736e10e5b6d9bba408cbac3fbcb267af
publicationDate 2008-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101172974-A
titleOfInvention Method for producing aztreonam amino acid salt
abstract The invention discloses a synthesis method for aztreonam salt. The method comprises the steps as follow: aztreonam is dissolved into organic solvent; the water solution of amino acid is dropped in the mixture; and the aztreonam salt is obtained by cooling and filtering the solution after full reaction. The invention is characterized in that the organic solvent is used as reaction solution, thereby ensuring the salt making reaction of aztreonam to be more completely with the high reaction yield; the used solvent can be recycled, thereby enabling the aztreonam amino acid salt to have better water-solubility and to be more easily to be made into preparations; and the salt is no longer mixed with the amino acid, thereby being more convenient for medicine use. The invention has the advantages of easy operation, high purity, low cost, and being suitable for mass production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113754651-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113754651-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012100382-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112645943-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101579336-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110898040-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102145001-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110898040-A
priorityDate 2007-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413790799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159203560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447733135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450345863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135747285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6137

Total number of triples: 50.